2025 MTI APAC Info Session: Australia Focused Join us for an informative session on the MedTech Innovator Asia Pacific Program together with Karen Parr from BioMelbourne Network and Dr. Hugh Paterson from Sydney Heart Valve! This session is for applicants in Australia/NZ, looking to accelerate your startup in medical devices, digital health and diagnostics. 📅 Date: Tuesday, 3 December 2024 🕒 Time: 1:00 PM to 2:00 PM AEDT (GMT+11) Discover how this program can support your startup’s growth today! 🔗 Click here to join via LinkedIn: https://lnkd.in/gd8aJGEz #Innovation #Healthcare #MedTech #MTIAPAC #MTIAPAC2025
MedTech Innovator Asia Pacific’s Post
More Relevant Posts
-
Breaking news: US MedTech startups are looking south for innovation. 🌎 Arissa Medical just completed their 3rd cohort of patients in Chile for their groundbreaking Syntra device. Why Latin America? • Faster patient recruitment • Lower costs • High-quality healthcare systems • Experienced investigators This trend is reshaping the global MedTech landscape. As someone who's been bridging US and LatAm MedTech for years, I'm excited to see this shift. What other benefits do you see in this approach? #MedTechInnovation #ClinicalTrials #LatAmHealthcare #bioaccess
To view or add a comment, sign in
-
The latest German Federal Association of Medical Technology Autumn Survey highlights several challenges, including rising costs and a projected 1.2% revenue increase in Germany for 2024. Despite these issues, the MedTech sector remains a vital job engine. 32% of companies are planning to expand their workforce, showing the industry's resilience and focus on innovation. There’s a strong call for regulatory improvements and a solid MedTech strategy to ensure that Germany remains a leader in healthcare innovation. The future is challenging, but full of potential. #MedTech #BVMed #HealthcareInnovation #JobGrowth #Germany
To view or add a comment, sign in
-
Latin America: The new frontier for MedTech innovation. Here's why it's heating up: 1. Top-notch medical professionals 2. Diverse patient populations 3. Streamlined regulatory processes 4. Cost-effective research options 5. Growing investment in healthcare infrastructure I've seen firsthand how LatAm trials can accelerate device development. Case in point: Sparta Biomedical's recent Ormi implant study. From concept to first-in-human trials, faster. Medtech leaders, are you leveraging LatAm's potential? Let's discuss how to make it happen. #MedTech #LatinAmerica #bioaccess
To view or add a comment, sign in
-
In 2023 Global MedTech TOP 100, showcasing the most influential companies in the industry. China continues to make significant strides with 22 companies making the list! 🇨🇳✨ From groundbreaking medical devices to advanced diagnostic solutions, these firms are leading the charge in transforming global healthcare. #GlobalMedTech #MedicalDevices #HealthcareInnovation #ChinaMedTech #Top100 #MedicalTechnology #HealthcareIndustry #Innovation #MedTechLeaders #BusinessGrowth
To view or add a comment, sign in
-
The Global Med Tech industry is valued at over $567 Billion today. What will it take to promote local manufacturing of medical devices and diagnostics in Least Developed Countries (LDCs) to meet their health needs and diversify their economies? WIPO, UN Technology Bank for LDCs and Medtronic invite you to join us for the Global Challenges Seminar on Driving MedTech Innovation Ecosystems in LDCs on Tuesday, October 1, 2024, from 2:00 p.m. to 4:20 p.m. CET, at WIPO Headquarters, Geneva, as well as online. This seminar will provide an opportunity to explore and discuss a forthcoming study that highlights the current state of MedTech innovation and access in LDCs. Topics will include: -The innovation culture and capacity for MedTech in LDCs, -The role of the intellectual property (IP) system, -Regulatory pathways, -Access to financing opportunities, and -Policies that can foster MedTech innovation and access. The event will also feature case studies from Bangladesh and Rwanda, highlighting the enablers of and barriers to MedTech innovation in LDCs. Event Details: Date: October 1, 2024 Time: 2:00 p.m. – 4:20 p.m. CET Location: WIPO Headquarters, Room 0.107, Geneva (with an option to join online) Program and registration details: Registration link: https://lnkd.in/ezEMrA_Y
Save the date: WIPO will host a seminar on driving medical technology (MedTech) innovation in least developed countries (LDCs) in Geneva on October 1, 2024 – https://lnkd.in/gG8X_n5C. This event, organized in collaboration with the UN Technology Bank for Least Developed Countries, and Medtronic, will explore the state of MedTech innovation in LDCs and discuss key enablers and barriers to innovation, based on case studies from Bangladesh and Rwanda. The Global Challenges colleagues are looking forward to welcoming you in Geneva! #WIPO #GlobalHealth #PublicHealth #Innovation #MedTech #IntellectualProperty #Research #HealthcareInnovation
To view or add a comment, sign in
-
Latin America: The next MedTech innovation hub? 🌎💡 I've seen it firsthand - LatAm is becoming a powerhouse for medical device trials. Why are smart MedTech companies flocking here? • Diverse patient populations • Cost-effective research • High-quality data collection • Streamlined approvals Chile's leading the charge: → 50% trial growth in 2 years → 1-1.5 month approval times → Universal healthcare = accessible patients The secret? Balancing innovation and safety. At bioaccess, we're helping MedTech companies tap into this potential. Which LatAm country will be the next clinical trial hotspot? #MedTechInnovation #LatAmHealthcare
To view or add a comment, sign in
-
🌍 📊 The MedTech industry in Europe is estimated to be worth over €160 billion, making it 26.4% of the world market. Currently, in Europe, there are over 35,000 MedTech companies. These companies invest heavily in creating advancing technologies that enhance the quality of life for patients and all stakeholders in healthcare. 🏢 With 92% of them being SMEs, they serve as key drivers of economic growth, contribute to employment opportunities across Europe, yet, most of them struggle to get their new innovations to market. Throughout the years, we have seen that many of these companies do not have the right strategies or support in regards to market entry, field execution and most importantly, demonstrating the value their products will bring to society. At ValueConnected, we have over a decade of experience in helping companies worldwide make sure they're innovations get to market. And as we grow ourselves, we are always open to help more of you. If you would like to learn more, please do make sure to reach out by scheduling a quick meeting with our CEO and Founder, Ernesto M. Nogueira. Partner with us and let our commercial expertise and market knowledge take your latest medical innovation to the next level. 🌐 Schedule a meeting: https://lnkd.in/eiuC4UCA #MedTech #HealthCare #Innovation #Europe
To view or add a comment, sign in
-
In the bustling arena of medtech, bridging the communication gap between the US and Latin America is crucial. The hurdles, ranging from language barriers to fragmented resources, challenge innovation. Yet, stories of collaboration show the potential of overcoming these obstacles. Imagine a world where Latin American hospitals seamlessly connect with US medtech companies to drive first-in-human clinical trials. This is where bioaccess® steps in, offering expertise as a Medtech CRO to facilitate early feasibility trials in Latin America. By fostering these connections, we can unlock new horizons for medical advancements. Let's work together to create a bridge for innovation. 🌉✨ #Medtech #ClinicalTrials https://lnkd.in/eJg3R9Xs
To view or add a comment, sign in
-
Upcoming (October 1, 2024): Seminar on Driving Medical Technology (MedTech) Innovation Ecosystems in Least Developed Countries (LDCs). Hosted by World Intellectual Property Organization – WIPO, and organized in cooperation with UN Technology Bank for Least Developed Countries, and Medtronic, the seminar will explore the current state of MedTech innovation and access in LDCs. What to expect: ☑️ A comprehensive overview of the MedTech ecosystem, including innovation capacity, the role of intellectual property (IP), and policies that promote MedTech innovation in LDCs. ☑️ Case studies from Bangladesh and Rwanda to learn about key enablers and barriers to MedTech innovation. Register here to attend online or in-person: https://lnkd.in/deU-xRW5 #WIPO #WIPOknowledge #GlobalHealth #PublicHealth #Innovation #MedTech #IntellectualProperty #Research #HealthcareInnovation
To view or add a comment, sign in
-
🚀 Exciting Opportunity for MedTech Innovators! 🚀 Join the UK MedTech to Market Programme and unlock your company's potential for market success! The MedTech landscape is evolving, along with the opportunities and challenges of bringing groundbreaking medical technology to those who need it most. Designed for MedTech companies, the UK MedTech to Market Programme is your roadmap to navigating the industry and achieving sustained success. The programme is split into two key phases for a full spectrum of support: ✔ Day 1 - Fit to Supply: Learn how to get your MedTech company market ready by understanding what it takes to enter the supply chain. Prepare to meet the rigorous regulatory, quality and operational standards that make you stand out to MedTech buyers. ✔ Day 2 - Ready to Supply: Discover how to upskill and strategise to enter and thrive in the MedTech market. Master the UK's regulatory environment, ace approval processes, safeguard intellectual property and craft sales and marketing strategies that resonate. ✨ Whether you're fine-tuning your prototype or on the brink of market launch, our programme is here to support your journey every step of the way. Find out more and register now: Day 1 - Fit to Supply 👉🏻 https://buff.ly/47jNfHT Day 2 - Ready to Supply 👉🏻 https://buff.ly/3ZkC0gb #MedTech #MarketSuccess #GrowthStrategy
To view or add a comment, sign in
3,565 followers
Good to see you on this Dr. Hugh.